Hill, RM;
Kuijper, S;
Lindsey, JC;
Petrie, K;
Schwalbe, EC;
Barker, K;
Boult, JKR;
... Clifford, SC; + view all
(2015)
Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease.
Cancer Cell
, 27
(1)
pp. 72-84.
10.1016/j.ccell.2014.11.002.
Preview |
Text
Hargrave_1-s2.0-S153561081400453X-main.pdf - Published Version Download (6MB) | Preview |
Abstract
We undertook a comprehensive clinical and biological investigation of serial medulloblastoma biopsies obtained at diagnosis and relapse. Combined MYC family amplifications and P53 pathway defects commonly emerged at relapse, and all patients in this group died of rapidly progressive disease postrelapse. To study this interaction, we investigated a transgenic model of MYCN-driven medulloblastoma and found spontaneous development of Trp53 inactivating mutations. Abrogation of p53 function in this model produced aggressive tumors that mimicked characteristics of relapsed human tumors with combined P53-MYC dysfunction. Restoration of p53 activity and genetic and therapeutic suppression of MYCN all reduced tumor growth and prolonged survival. Our findings identify P53-MYC interactions at medulloblastoma relapse as biomarkers of clinically aggressive disease that may be targeted therapeutically.
| Type: | Article |
|---|---|
| Title: | Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ccell.2014.11.002 |
| Publisher version: | http://doi.org/10.1016/j.ccell.2014.11.002 |
| Language: | English |
| Additional information: | Copyright © This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/). |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1466007 |
Archive Staff Only
 |
View Item |
